Cancer research is progressing thanks to the daily contribution of many scientists worldwide. However, only a few of these scientists make revolutionary contributions that make clinical impact and change the way we think about cancer therapy.
In the first part of the meeting, IBSA Foundation will present three “GIANTS”, whose contribution has led to highly innovative and clinically-effective therapies.
In the final part of the meeting, Prof. Solange Peters, the future President for year 2020-2021 of the European medical oncologists (ESMO), will present an overview on how this pioneering research has been moved to the clinic through well-designed clinical trials.
The Forum is organized by IBSA Foundation for scientific research in collaboration with Franco Cavalli (Foundation for the Institute of Oncology Research – IOR) and Andrea Alimonti (Università della Svizzera italiana – USI, IOR and IBSA Foundation).
This special edition of the IBSA scientific Forum will take place within the 15th International Conference on Malignant Lymphoma (ICML), which has become the most important international gathering in the field of research and treatment of lymphoid neoplasms, organized by Professor Cavalli and the Foundation for the Institute of Oncology Research (IOR).
The forum is free and open not only to ICML participants but to anyone interested.
Location: Auditorium USI – Lugano – Switzerland
Date: June 21, 2019
Prof. Carl June, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA
Prof. Napoleone Ferrara, UC San Diego School of Medicine, USA
Prof. Dr. Michael Hall, Biozentrum University of Basel, Germany
Prof. Solange Peters, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland